ROBERT GERSTMAN: Open Payments
NPI 1689680795 · DANVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,231 in 20 payments from 8 companies in 2025. Trend: 2023 $1,215 · 2024 $1,510 · 2025 $1,231
Food & beverage: $1,120Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $396 |
| Axsome Therapeutics, Inc. | 2 | $250 |
| Otsuka America Pharmaceutical, Inc. | 4 | $190 |
| ABBVIE INC. | 2 | $141 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 3 | $77 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| Alkermes, Inc. | 1 | $20 |
Products named: Auvelity, UZEDY, VRAYLAR, ABILIFY MAINTENA, AUSTEDO XR, INGREZZA, COBENFY, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
